Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 117
Infectious Diseases Drugs 88
Endocrine and Metabolic Disorders Drugs 75
Central Nervous System Drugs 59
Genomics 59
Immune Disorders Drugs 57
Pharmaceuticals 45
Drug Discovery 41
Diabetes Drugs 41
Prostate Cancer Drugs 41
Vaccines 40
Biopharmaceuticals 37
Urological Disorders Drugs 35
Clinical Trials 33
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 30
Biotechnology 28
Cardiovascular Drugs 26
Musculoskeletal Disorders Drugs 26
Leukemia Drugs 25
Liver and Kidney Disorders Drugs 25
Immunosuppressive Drugs 23
Antibiotics 22
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Stem Cells 19
Surgical Procedures 19
Oncology 18
Analgesics 17
Optical 14
Urology and Nephrology 13
Lung Cancer Drugs 13
Medical Devices 13
Infusions and Injectables 12
Diagnostics 12
Drug Delivery 12
Bladder Cancer Drugs 11
Dermatology 11
Healthcare Services 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Respiratory Drugs 8
Pharmaceutical Manufacturing 8
Pulmonary Medicine 7
Neurology 7
Lymphoma Drugs 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Biomaterials 6
Hearing Aids and Implants 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Needles and Syringes 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Pediatrics 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Skin Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Palliative Care 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anatomy 1
Endocrinology 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

1,131 Results (Page 25 of 57)
- Relevance
  Sort by

Transthyretin Amyloidosis Treatment Market Report and Forecast 2023-2031

 Report
March 2023
147 Pages
Global

From

€4592EUR$4,949USD£3,831GBP

Hairy Cell Leukemia - Global Strategic Business Report

 Report
November 2026
273 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Acute Myeloid Leukemia Therapeutics Market (AML) - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

Myelodysplastic Syndrome Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

Hairy Cell Leukemia Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
197 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Viral Gastroenteritis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4166EUR$4,490USD£3,475GBP

Stargardt Disease Therapeutics - Global Strategic Business Report

 Report
November 2026
364 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Cutaneous T-Cell-Lymphoma Market - Global Forecast 2026-2032

 Report
January 2026
195 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

Leukemia Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
120 Pages
Global

From

€4408EUR$4,750USD£3,677GBP

Acute Myeloid Leukemia Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
137 Pages
Global

From

€4408EUR$4,750USD£3,677GBP

FLT3 Antagonists Market - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

Liposome Drug Delivery - Global Strategic Business Report

 Report
November 2026
576 Pages
Global

From

€5428EUR$5,850USD£4,528GBP

Hairy Cell Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
May 2026
110 Pages
Global

From

€4408EUR$4,750USD£3,677GBP

Small Cell Lung Cancer Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4166EUR$4,490USD£3,475GBP

Mantle Cell Lymphoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4166EUR$4,490USD£3,475GBP

Diabetic Neuropathy Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
February 2022
94 Pages
Global

From

€3200EUR$3,694USD£2,763GBP

Lung Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4166EUR$4,490USD£3,475GBP

FLT3 Inhibitors Market - Global Forecast 2026-2032

 Report
January 2026
190 Pages
Global

From

€3289EUR$3,545USD£2,744GBP

€3655EUR$3,939USD£3,049GBP

Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
August 2023
106 Pages
Global

From

€2320EUR$2,500USD£1,935GBP

Autoimmune Collaboration and Licensing Deals 2016-2026

 Report
October 2026
550 Pages
Global

From

€3707EUR$3,995USD£3,092GBP

1,131 Results (Page 25 of 57)
- 1
- 23
- 24
- 25
- 26
- 27

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.